Back to News
Market Impact: 0.05
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Source: zacks.com
Healthcare & Biotech
The State Street SPDR S&P Pharmaceuticals ETF (XPH) provides passive exposure to the Healthcare - Pharma segment of the equity market. It launched on June 19, 2006; the article provides no new market-moving information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Humana Stock Jumps on Raised Medicare Advantage Ratings
- Premarket movers: Humana rallies; SpaceX deal sends telco stocks down
- Baird upgrades Humana stock rating on margin recovery outlook
- William Blair downgrades Alignment Healthcare stock rating on cost pressures